Who wields power in biopharma is changing.

Our journalists will lead a dialogue on this change — who’s rising, who’s falling and how the drug business will look very different at the end of the decade. Join us for a set of exclusive conversations and interviews you won’t get anywhere else.

More than any time in the last decade, the top of the pharmaceutical world is unstable. New and growing biotechs are ascendant. Major pharma players are stagnating — or in decline. The rise of China has just begun, and the US has no answer yet. Startups and AI companies are in a race against legacy players to own the future of drug development.

And when you need a moment to reflect and talk about what you’ve learned, the Endpoints Hub will give you a place to step back from the frenzy, to meet and to connect.

Register now – 10% off Discount code: JPM_MASSBIO10